Garcinia xanthones as orally active antitumor agents

Journal of Medicinal Chemistry

Volumn 56, Issue 1, 2013, Pages 276-292

  Zhang, Xiaojin ^a   Li, Xiang ^a   Sun, Haopeng ^a   Wang, Xiaojian ^b   Zhao, Li ^a   Gao, Yuan ^a   Liu, Xiaorong ^a   Zhang, Shenglie ^a   Wang, Yanyan ^a   Yang, Yingrui ^a   Zeng, Su ^c   Guo, Qinglong ^a   You, Qidong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GAMBOGIC ACID; XANTHONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG DETERMINATION; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; GARCINIA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PHYSICAL CHEMISTRY;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; GARCINIA; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MEMBRANES, ARTIFICIAL; MICE; NEOPLASM TRANSPLANTATION; PERMEABILITY; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSPLANTATION, HETEROLOGOUS; XANTHONES;

EID: 84872338112     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm301593r     Document Type: Article

References (57)

1. Newman, D. J.; Cragg, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010 J. Nat. Prod. 2012, 75, 311-335
2. Butler, M. S. Natural products to drugs: Natural product-derived compounds in clinical trials Nat. Prod. Rep. 2008, 25, 475-516
3. Mishra, B. B.; Tiwari, V. K. Natural products: An evolving role in future drug discovery Eur. J. Med. Chem. 2011, 46, 4769-4807
4. Auterhoff, H.; Frauendorf, H.; Liesenklas, W.; Schwandt, C. The chief constituents of gamboges resin. 1. Chemistry of gamboge Arch. Pharm. 1962, 295, 833-846
5. Han, Q. B.; Xu, H. X. Caged Garcinia xanthones: Development since 1937 Curr. Med. Chem. 2009, 16, 3775-3796
6. Ollis, W. D.; Ramsy, M. V. J.; Sutherland, I. O.; Mongkolsuk, S. The constitution of gambogic acid Tetrahedron 1965, 21, 1453-1470
7. Ren, Y.; Yuan, C.; Chai, H. B.; Ding, Y.; Li, X. C.; Ferreira, D.; Kinghorn, A. D. Absolute configuration of (-)-gambogic acid, and antitumor agent J. Nat. Prod. 2011, 74, 460-463
8. Asano, J.; Chiba, K.; Tada, M.; Yoshii, T. Cytotoxic xanthones from Garcinia hanburyi Phytochemistry 1996, 41, 815-820
9. Han, Q. B.; Wang, Y. L.; Yang, L.; Tso, T. F.; Qiao, C. F.; Song, J. Z.; Xu, L. J.; Chen, S. L.; Yang, D. J.; Xu, H. X. Cytotoxic polyprenylated xanthones from the resin of Garcinia hanburyi Chem. Pharm. Bull. 2006, 54, 265-267
10. Cao, S. G.; Sng, V. H. L.; Wu, X. H.; Sim, K. Y.; Tan, B. H. K.; Pereira, J. T.; Goh, S. H. Novel cytotoxic polyprenylated xanthonoids from Garcinia gaudichaudii (Guttiferae) Tetrahedron 1998, 54, 10915-10924
11. Thoisen, O.; Fahy, J.; Dumontet, V.; Chiaroni, A.; Riche, C.; Tri, M. V.; Sevenet, T. Cytotoxic prenylxanthones from Garcinia bracteata J. Nat. Prod. 2000, 63, 441-446
12. Wu, Z. Q.; Guo, Q. L.; You, Q. D.; Zhao, L.; Gu, H. Y. Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells Biol. Pharm. Bull. 2004, 27, 1769-1774
13. Zhang, H. Z.; Kasibhatla, S.; Wang, Y.; Herich, J.; Guastella, J.; Tseng, B.; Drewe, J.; Cai, S. X. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay Bioorg. Med. Chem. 2004, 12, 309-317
14. Yang, Y.; Yang, L.; You, Q. D.; Nie, F. F.; Gu, H. Y.; Zhao, L.; Wang, X. T.; Guo, Q. L. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes Cancer Lett. 2007, 256, 259-266
15. Zhao, L.; Zhen, C.; Wu, Z.; Hu, R.; Zhou, C.; Guo, Q. General pharmacological properties, developmental toxicity, and analgesic activity of gambogic acid, a novel natural anticancer agent Drug Chem. Toxicol. 2010, 33, 88-96
16. Gu, H.; Wang, X.; Rao, S.; Wang, J.; Zhao, J.; Ren, F. L.; Mu, R.; Yang, Y.; Qi, Q.; Liu, W.; Lu, N.; Ling, H.; You, Q.; Guo, Q. Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells Mol. Cancer Ther. 2008, 7, 3298-3305
17. Huang, H.; Chen, D.; Li, S.; Li, X.; Liu, N.; Lu, X.; Liu, S.; Zhao, K.; Zhao, C.; Guo, H.; Yang, C.; Zhou, P.; Dong, X.; Zhang, C. Guanmei; Dou, Q. P.; Liu, J. Gambogic acid enhances proteasome inhibitor-induced anticancer activity Cancer Lett. 2011, 301, 221-228
18. Yu, J.; Guo, Q. L.; You, Q. D.; Zhao, L.; Gu, H. Y.; Yang, Y.; Zhang, H. W.; Tan, Z.; Wang, X. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells Carcinogenesis 2007, 28, 632-638
19. Qiang, L.; Yang, Y.; You, Q. D.; Ma, Y. J.; Yang, L.; Nie, F. F.; Gu, H. Y.; Zhao, L.; Lu, N.; Qi, Q.; Liu, W.; Wang, X. T.; Guo, Q. L. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: An in vitro and in vivo study Biochem. Pharmacol. 2008, 75, 1083-1092
20. Yi, T.; Yi, Z.; Cho, S. K.; Luo, J.; Pandey, M. K.; Aggarwal, B. B.; Liu, M. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling Cancer Res. 2008, 68, 1843-1850
21. Li, C.; Lu, N.; Qi, Q.; Li, F.; Ling, Y.; Chen, Y.; Qin, Y.; Li, Z.; Zhang, H.; You, Q.; Guo, Q. Gambogic acid inhibits tumor cell adhesion by suppressing integrin β1 and membrane lipid rafts-associated integrin signaling pathway Biochem. Pharmacol. 2011, 82, 1873-1883
22. Zhai, D.; Jin, C.; Shiau, C. W.; Kitada, S.; Satterthwait, A. C.; Reed, J. C. Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins Mol. Cancer Ther. 2008, 7, 1639-1646
23. Yang, J.; Li, C.; Ding, L.; Guo, Q.; You, Q.; Jin, S. Gambogic acid deactivates cytosolic and mitochondrial thioredoxins by covalent binding to the functional domain J. Nat. Prod. 2012, 75, 1108-1116
24. Qin, Y.; Meng, L.; Hu, C.; Duan, W.; Zuo, Z.; Lin, L.; Zhang, X.; Ding, J. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain Mol. Cancer Ther. 2007, 6, 2429-2440
25. Wang, T.; Wei, J.; Qian, X.; Ding, Y.; Yu, L.; Liu, B. Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells Cancer Lett. 2008, 262, 214-222
26. Kasibhatla, S.; Jessen, K. A.; Maliartchouk, S.; Wang, J. Y.; English, N. M.; Drewe, J.; Qiu, L.; Archer, S. P.; Ponce, A. E.; Sirisoma, N.; Jiang, S.; Zhang, H. Z.; Gehlsen, K. R.; Cai, S. X.; Green, D. R.; Tseng, B. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid Proc. Natl. Acad. Sci. U S A 2005, 102, 12095-12100
27. Pandey, M. K.; Sung, B.; Ahn, K. S.; Kunnumakkara, A. B.; Chaturvedi, M. M.; Aggarwal, B. B. Gambogic acid, a novel ligand for transferring receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway Blood 2007, 110, 3517-3525
28. Davenport, J.; Manjarrez, J. R.; Peterson, L.; Krumm, B.; Blagg, B. S.; Matts, R. L. Gambogic acid, a natural product inhibitor of Hsp90 J. Nat. Prod. 2011, 74, 1085-1092
29. Wang, X.; Chen, Y.; Han, Q. B.; Chan, C. Y.; Wang, H.; Liu, Z.; Cheng, C. H.; Yew, D. T.; Lin, M. C.; He, M. L.; Xu, H. X.; Sung, J. J.; Kung, H. F. Proteomic identification of molecular targets of gambogic acid: Role of stathmin in hepatocellular carcinoma Proteomics 2009, 9, 242-253
30. Palempalli, U. D.; Gandhi, U.; Kalantari, P.; Vunta, H.; Arner, R. J.; Narayan, V.; Ravindran, A.; Prabhu, K. S. Gambogic acid covalently modifies IkappaB kinase-beta subunit to mediate suppression of lipopolysaccharide-induced activation of NF-kappaB in macrophages Biochem. J. 2009, 419, 401-409
31. Sun, H.; Chen, F.; Wang, X.; Liu, Z.; Yang, Q.; Zhang, X.; Zhu, J.; Qiang, L.; Guo, Q.; You, Q. Studies on chemical modification and biology of a natural product, Gambogic acid (IV): Identification of IκB Kinase-beta (IKKβ) as the molecular target and determination of the pharmacophoric scaffold Eur. J. Med. Chem. 2012, 51, 110-123
32. Wang, J.; Zhaoaaa, Li.; Hu, Y.; Guo, Q.; Zhang, L.; Wang, X.; Li, N.; You, Q. Studies on chemical modification and biology of a natural product, gambogic acid (I): Synthesis and biological evaluation of oxidized analogues of gambogic acid Eur. J. Med. Chem. 2009, 44, 2611-2620
33. Chantarasriwong, O.; Batova, A.; Chavasiri, W.; Theodorakis, E. A. Chemistry and biology of the caged Garcinia xanthones Chem.-Eur. J. 2010, 16, 9944-9962
34. He, L.; Ling, Y.; Fu, L.; Yin, D.; Wang, X.; Zhang, Y. Synthesis and biological evaluation of novel derivatives of gambogic acid as anti-hepatocellualar carcinoma agents Bioorg. Med. Chem. 2012, 22, 289-292
35. Batova, A.; Lam, T.; Wascholowski, V.; Yu, A. L.; Giannis, A.; Theodorakis, E. A. Synthesis and evaluation of caged Garcinia xanthones Org. Biomol. Chem. 2007, 5, 494-500
36. Zhang, X.; Li, X.; Sun, H.; Jiang, Z.; Tao, L.; Gao, Y.; Guo, Q.; You, Q. Synthesis and evaluation of novel aza-caged Garcinia xanthones Org. Biomol. Chem. 2012, 10, 3288-3299
37. Chantarasriwong, O.; Cho, W. C.; Batova, A.; Chavasiri, W.; Moore, C.; Rheingold, A. L.; Theodorakis, E. A. Evaluation of the pharmacophoric motif of the caged Garcinia xanthones Org. Biomol. Chem. 2009, 5, 4886-4894
38. Wang, X.; Lu, N.; Yang, Q.; Gong, D.; Lin, C.; Zhang, S.; Xi, M.; Gao, Y.; Wei, L.; Guo, Q.; You, Q. Studies on chemical modification and biology of a natural product, gambogic acid (III): Determination of the essential pharmacophore for biological activity Eur. J. Med. Chem. 2011, 46, 1280-1290
39. Kuemmerle, J.; Jiang, S.; Tseng, B.; Kasibhatla, S.; Drewe, J.; Cai, S. X. Synthesis of caged 2,3,3a,7a-terahydro-3,6-methanobenzofuran-7(6 H)-ones: Evaluating the minimum structure for apoptosis induction by gambogic acid Bioorg. Med. Chem. 2008, 16, 4233-4241
40. Wang, J.; Ma, J.; You, Q.; Zhao, L.; Wang, F.; Li, C.; Guo, Q. Studies on chemical modification and biology of a natural product, gambogic acid (II): Synthesis and bioevaluation of gambogellic acid and its derivatives Eur. J. Med. Chem. 2010, 45, 4343-4353
41. Wang, X.; Lu, N.; Yang, Q.; Dai, Q.; Tao, L.; Guo, X.; Guo, Q.; You, Q. Spectacular modification of gambogic acid on microwave irradiation in methanol: Isolation and structure identification of two products with potent anti-tumor activity Bioorg. Med. Chem. 2010, 20, 2438-2442
42. Li, X.; Zhang, X.; Sun, H.; Zhang, L.; Gao, Y.; Wang, J.; Guo, Q.; You, Q. Synthesis and anti-tumor evaluation of novel C-37 modified derivatives of gambogic acid Chin. J. Chem. 2012, 30, 1083-1091
43. Sun, H.-P.; Liu, Z.-L.; Xue, X.; Gao, Y.; Zhang, L.; Guo, Q.-L.; You, Q.-D. Studies on chemical structure modification and structure-activity relationship of derivatives of gambogic acid at C(39) Chem. Biodiv. 2012, 9, 1579-1590
44. Zhang, X.-J; Li, X.; Yang, Y.-R.; Sun, H.-P.; Gao, Y.; Zhang, L.; Wang, J.-X.; Guo, Q.-L.; You, Q.-D. Studies on chemical structure modification and structure-activity relationship of derivatives of gambogic acid at C(34) Chem. Biodiv. 2012, 9, 2295-2308
45. Nicolaou, K. C.; Li, J. "Biomimetic" cascade reactions in organic synthesis: Construction of 4-oxatricyclo[4.3.1.0]decan-2-one systems and total synthesis of 1- O -methylforbesione via tandem Claisen rearrangement/Diels-Alder reaction Angew. Chem., Int. Ed. 2001, 40, 4264-4268
46. Tisdale, E. J.; Li, H.; Vong, B. G.; Kim, S. H.; Theodorakis, E. A. Regioselective synthesis of the tricyclic core of lateriflorone Org. Lett. 2003, 5, 1491-1494
47. Nicolaou, K. C.; Sasmal, P. K.; Xu, H. Biomimetically inspired total synthesis and structure activity relationships of 1- O -methyllateriflorone. 6π Electrocyclizations in organic synthesis J. Am. Chem. Soc. 2004, 126, 5493-5501
48. Tisdale, E. J.; Slobodov, I.; Theodorakis, E. A. Unified synthesis of caged Garcinia natural products based on a site-selective Claisen/Diels-Alder/ Claisen rearrangement Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 12030-12035
49. Li, N.-G.; Wang, J.-X.; Liu, X.-R.; Lin, C.-J.; You, Q.-D.; Guo, Q.-L. A novel and efficient route to the construction of the 4-oxa-tricyclo[4.3.1.0] decan-2-one scaffold Tetrahedron Lett. 2007, 48, 6586-6589
50. Liu, Z.-L.; Wang, X.-J.; Li, N.-G.; Sun, H.-P.; Wang, J.-X.; You, Q.-D. Total synthesis of aldehyde-containing Garcinia natural products isomorellin and gaudichaudione A Tetrahedron 2011, 67, 4774-4779
51. Li, X.; Zhang, X.; Yu, Z.; Liu, X.; You, Q.; Guo, Q. Microwave-assisted Claisen rearrangement/Diels-Alder cascade reaction for the synthesis of caged Garcinia natural products and analogues J. Chem. Res. 2012, 35, 630-633
52. Avdeef, A.; Tsinman, O. Miniaturized rotating disk intrinsic dissolution rate measurement: Effect of buffer capacity in comparisons to traditional Wood's apparatus Pharm. Res. 2008, 25, 2613-2627
53. Avdeef, A.; Bucher, J. J. Accurate measurements of the concentration of hydrogen ions with a glass electrode: Calibrations using the Prideaux and other universal buffer solutions and a computer-controlled automatic titrator Anal. Chem. 1987, 50, 2137-2142
54. Egan, W. J.; Merz, K. M.; Baldwin, J. J. Prediction of drug absorption using multivariate statistics J. Med. Chem. 2000, 43, 3867-3877
55. Egan, W. J.; Lauri, G. Prediction of intestinal permeability Adv. Drug Delivery Rev. 2002, 54, 273-289
56. Kelder, J.; Grootenhuis, P. D.; Bayada, D. M.; Delbressine, L. P.; Ploemen, J.-P. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs Pharm. Res. 1999, 16, 1514-1519
57. Hollingshead, M. G. Antitumor efficacy testing in rodents J. Nat. Cancer Inst. 2008, 100, 1500-1510